Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
54,832,749
-
Shares change
-
+11,808,262
-
Total reported value, excl. options
-
$893,221,923
-
Value change
-
+$193,920,385
-
Put/Call ratio
-
55.42%
-
Number of buys
-
71
-
Number of sells
-
-37
-
Price
-
$16.29
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2018
133 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q3 2018.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,832,749 shares
of 114,331,829 outstanding shares and own 47.96% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (10,359,666 shares), FMR LLC (7,637,402 shares), FRANKLIN RESOURCES INC (5,358,265 shares), BlackRock Inc. (3,469,531 shares), Casdin Capital, LLC (2,550,000 shares), Polaris Venture Management Co. V, L.L.C. (2,473,186 shares), Vanguard Group Inc (2,448,279 shares), Artal Group S.A. (2,190,000 shares), STATE STREET CORP (1,954,840 shares), and Partner Fund Management, L.P. (1,501,258 shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.